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Since the first reported case of COVID-19 in December 2019, there have been over 100 
million cases and over 3 million deaths due to complications from the coronavirus. The 
framework of health systems and economies across the globe have been significantly taxed as 
a result of the abundance of cases, with hospitals going over maximum capacity and many 
businesses having to close their doors permanently. As a result, people have become isolated 
and divided over solutions for combating the spread of the virus. Increasing evidence supports 
that COVID-19 is mainly spread through airborne droplets, such as from talking, coughing, and 
sneezing. Face masks could be an inexpensive and effective option for slowing the spread of 
the virus. A study of Beijing households in March 2020 revealed that face mask use in 
households with at least one positive case reduced transmission of the virus by 79%.1 Face 
masks, whether they be cloth or medical, are an effective solution for preventing the spread of 
COVID-19.  
 
In a recent study published by Li et. al in PLOS One, researchers simulated the spread 
of the virus based on varying levels of mask wearing.2 The model used for the simulation 
(known as a SEIR model) is popularly used to simulate disease outbreaks, like the COVID-19 
outbreak. The model works by adjusting the following populations over time: people susceptible 
to the virus (S), people exposed but not showing symptoms (E), people infected (I), and 
recovered individuals (R). Using this data, the approximate rate of infection of the virus can be 
calculated, without accounting for any preventative measures such as mask wearing and social 
distancing. The goal is to compare how accounting for mask wearing in different capacities (as 
well as the varying effectiveness of different mask styles) could affect the rate at which people 
become infected with the virus. 
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When conducting the simulation, the researchers took into consideration access to 
medical resources, population densities, and cultures that might affect mask wearing and 
transmission rates. The approximate percentage of droplets stopped from escaping the mouth 
by a mask (40-75%), the amount of people potentially wearing a mask at any given moment (8-
100%), and the availability of masks to the population (5-100%) were tested by the researchers 
at these specific ranges to represent different situations throughout the world. For example, 
some industrialized countries can produce masks for almost all of their population and have a 
reserve readily available. Countries that are less developed or depend on other countries for 
goods may experience a shortage of masks. 
 
Switzerland, which only produces enough masks to accommodate around 30% of its 
population, relies on other countries to provide an adequate number of masks.3 If countries 
producing many masks decide to keep them mainly for themselves, Switzerland and countries 
in similar situations could be left to face the dire consequences of a severe COVID-19 outbreak 
without any means to stop it. The governments of big mask-producing countries have an 
enormous impact on global supply chains depending on their responses. On March 8, 240,000 
face masks from Germany that were bound for Switzerland were returned as the country 
announced a national ban on the export of medical equipment.3 State-centered politics like this 
could lead to the downfall of an effective global response by preventing needful countries from 
receiving medical equipment. 
 
The final results of the simulation showed that the rate of infection dropped by more than 
20% in scenarios where over half of the population wore masks.  This rate increased to more 
than 70% in populations where everyone wore masks. The only scenarios that did not exhibit a 
significant drop in infection rate were those where only 8% of the population were estimated to 
be wearing masks. This data further supports the benefit of a global call to action for enforcing 
mask-wearing guidelines for all public areas, not just at the jurisdiction of businesses. Although 
it is implausible to reach a 100% rate of mask-wearing, improving mask-wearing rates would 
significantly decelerate transmission rates. 
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In practical situations, a low rate of mask-wearing could be attributed to a shortage of 
medical supplies, unwillingness to wear a mask, lax government attitudes, underlying medical 
conditions, or a combination of these factors. In a country such as the United States where 
medical supplies and cloth face masks are readily available, the use of a face mask could 
significantly slow down the rate of transmission, especially considering the potential for 
increased travel and social gatherings as summer approaches. 
 
Although the Pfizer and Moderna COVID-19 vaccines are being distributed around the 
world, the vaccine could take a while to reach the entire population of and be effective in a large 
country like the U.S. In Pennsylvania, Governor Tom Wolf proposed that on April 19, all 
Pennsylvania residents will be able to get a COVID-19 vaccine if they wish. Despite this, 
appointments may be scarce and still take place for many months after this date. Along with 
this, the process of being vaccinated takes about a month to complete.4 In third-world countries, 
the wait for the vaccine could be even longer. The potential for a long wait for distribution of the 
vaccine further reinforces the need to wear masks in order to slow down the rapidly increasing 
curve of the virus. 
 
With this in mind, the vaccine itself may not completely return society back to normal 
right away. The effectiveness of the vaccine and the percentage of people who actually get the 
vaccine will greatly impact the spread of the virus in the future. Even if the vaccine is highly 
effective, if less than half of a population gets it, the efforts to reduce the spread will be largely 
futile. This is because there would still be potential for those who have not received the vaccine 
to spread and experience severe symptoms of COVID-19.  
 
Like other viruses, the concept of herd immunity applies to the virus that causes COVID-
19. Herd immunity is the idea that almost all of a population has become immune to a specific 
virus; this reduces the spread of the virus because the number of people who can become 
infected and spread it have been significantly reduced.5 In this case, if someone has a 
contagious virus and is not immune to it, it is unlikely they will spread it to anyone else 
considering most people are vaccinated or immune. Herd immunity can be obtained through 
either a large proportion of people gaining immunity from exposure to a virus or through 
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vaccination. Immunity from exposure to the virus risks developing symptoms and complications 
that not only could have negative health consequences but could lead to death. Along with this, 
the antibodies produced from being infected with the virus likely only last in the immune system 
for around 8 months, according to the National Institute of Health.6 For these reasons, 
vaccination is a much less dangerous way of effectively obtaining immunity. Historically, herd 
immunity against Measles requires about a 95% vaccination rate and herd immunity against 
Polio requires around an 80% vaccination rate.5 The proportion of people exactly needed to 
induce herd immunity with COVID-19 is unknown, but estimates by researchers show that herd 
immunity may occur around a  50-70% vaccination rate.7 Although this estimate is not as 
intense as those for Measles and Polio, this does not mean COVID-19 should not be taken 
seriously. COVID-19 is highly contagious and has already caused many deaths worldwide. A 
high vaccination rate and reaching herd immunity is also vital for younger children unable to 
receive the vaccine as well as anyone else who may not be able to due to health or personal 
reasons. It will take a combination of vaccinations, mask wearing, and social distancing to reach 
herd immunity as fast as possible. 
 
Analysis by the British Medical Journal shows that the Pfizer vaccine has a 95% efficacy 
rate after two doses.8 Assuming this is accurate, the curve of infection should begin to slow 
down if most of a population gets the vaccine. Additionally, preliminary research indicates that 
those who are vaccinated are less likely to transmit SARS-Cov-2, but more research is 
necessary to verify this.9 Encouraging social distancing and enforcing mask-wearing throughout 
2021 would lessen the likelihood that those who have not received the vaccine would become 
infected. Further research on COVID-19 vaccines needs to be conducted in order to identify the 
full effects of the vaccines. At this time it is known that those who are vaccinated will be immune 
from the illnesses caused by the virus, but there may be a chance that they can still spread the 
virus. Continuing mask-wearing also prevents the spread of the virus by reducing exposures 
from those who are already vaccinated but may still carry and spread the virus. Those who are 
vaccinated could potentially be asymptomatic carriers, although vaccinated individuals are 
thought to be less likely to spread the virus. Combining aggressive mask-wearing restrictions 
with a highly effective vaccine would curb the increasing transmission rate faster than the help 
of a vaccine alone. 
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The impact of the vaccine, although potentially monumental, will likely hinge on social 
distancing and mask-wearing efforts. With the Biden administration in office, there are 
encouraging signs that a more assertive attitude towards mask-wearing and social distancing 
will be implemented in the U.S. In a speech in Delaware, Biden stated that he “will mandate 
mask-wearing in all federal buildings and all interstate transportation because masks save lives 
- period”.10 As of March 8, five states have lifted their mask mandate requirements for public 
places, namely Texas, Mississippi, Montana, Iowa, and North Dakota.11 These states join the 11 
states that never required masks in the first place. States should be enforcing mask-wearing to 
expedite the process of lowering the number of COVID-19 cases. Vaccination efforts will be 
most effective when assisted by mask-wearing and social distancing. The focus should be to 
aggressively combine mask-wearing, vaccination, and social distancing to reach a point that 
society can return to normal. Attempting to open up consumer sectors without requiring mask-
wearing while infection rates are still high will only repress the potential effects of the vaccine. 
Although COVID-19 has dampened the lives of many thus far, a more assertive approach 
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